State Street Corp Forte Biosciences, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	SELL	$0.46 - $0.78 $1,886 - $3,198	-4,100 Reduced 9.84%	37,564 $20,000
Q2 2022 Aug 15, 2022	SELL	$1.07 - $1.55 $485,281 - $702,977	-453,534 Reduced 91.59%	41,664 $54,000
Q1 2022 May 16, 2022	SELL	$1.21 - $2.24 $80,041 - $148,176	-66,150 Reduced 11.78%	495,198 $723,000
Q4 2021 Feb 14, 2022	BUY	$2.02 - $3.36 $196,861 - $327,452	97,456 Added 21.01%	561,348 $1.2 Million
Q3 2021 Nov 15, 2021	BUY	$2.96 - $36.67 $835,634 - $10.4 Million	282,309 Added 155.47%	463,892 $1.37 Million
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $5.72 Million - $7.72 Million	181,583 New	181,583 $6.11 Million
Q4 2020 Feb 16, 2021	SELL	$28.66 - $46.79 $118,623 - $193,663	-4,139 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$14.71 - $50.69 $60,884 - $209,805	4,139 New	4,139 $201,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.